American Association for Cancer Research Archives
Apr. 7, 2021—Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years.
Oct. 1, 2020—Portia Thomas grew up in Doerun, Georgia, a small, rural city named by pioneer hunters as a place with “a perfect doe run,” where the population has hovered around 800 people for the past 30 years. A childhood impression lifted her aspirations beyond her hometown and inspired her to pursue a career as a physician-scientist.
Mar. 12, 2020—Henry Henderson, PhD, was one of 16 researchers selected to participate in the American Association for Cancer Research’s Early-Career Investigator Hill Day on Feb. 27 in Washington, D.C. While there, he met with U.S. Sen. Marsha Blackburn and discussed funding for the National Institutes of Health and the National Cancer Institute with a member of the senator’s health policy staff.
Jan. 16, 2020—VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.
Oct. 17, 2013—A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days.
May. 30, 2013—A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer.
Apr. 4, 2013—Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014.
Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.